FAIM
GWPH

Financial Advocates Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Financial Advocates Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,242
Closed -$258K – 817
2020
Q4 		$258K Buy
+2,242
New +$251K 0.02% 609
2020
Q1 		– Sell
-2,282
Closed -$239K – 559
2019
Q4 		$239K Buy
+2,282
New +$256K 0.03% 450

Other funds holding GWPH

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Financial Advocates Investment Management's GWPH Position: Q1 2021 in Review

Financial Advocates Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 2,242 shares — an estimated $258K sold.

Financial Advocates Investment Management first reported a position in GWPH in Q4 2019 and held it in 2 quarters. The position peaked at $258K in Q4 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Financial Advocates Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Financial Advocates Investment Management sold 2,242 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $258K.
  • Financial Advocates Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 2 quarters.
  • Financial Advocates Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $258K in Q4 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Financial Advocates Investment Management's 13F filing for Q1 2021, filed 10 May 2021.